Inventor · disambiguated record
Aoy Tomita Mitchell
Also filed as: MITCHELL AOY T · MITCHELL AOY TOMITA
11 granted patents·29 pending applications·169 citations·filing 2007–2024
90Inventor score
Files withMEDICAL COLLEGE WISCONSIN INC21MITCHELL AOY TOMITA5NATERA INC4UNIV LOUISVILLE RES FOUND4MEDICAL COLLEGE OF WISCONSIN INC3
Top patents by PatentIndex Score
40 records- 0196US7799531B2Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphismsUNIV LOUISVILLE RES FOUND·Filed 2007·Granted Sep 21, 2010·64 cites·46 claims
- 0295US10472680B2Highly sensitive transplant rejection surveillance using targeted detection of donor specific cell free DNAMEDICAL COLLEGE OF WISCONSIN INC·Filed 2016·Granted Nov 12, 2019·23 cites·12 claims
- 0394US10385396B2Highly sensitive surveillance using detection of cell free DNAMEDICAL COLLEGE OF WISCONSIN INC·Filed 2013·Granted Aug 20, 2019·24 cites·12 claims
- 0494US8609338B2Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphismsMITCHELL AOY TOMITA·Filed 2010·Granted Dec 17, 2013·37 cites·8 claims
- 0590US8399195B2Detecting genetic abnormalitiesMITCHELL AOY TOMITA·Filed 2012·Granted Mar 19, 2013·10 cites·12 claims
- 0688US8663921B2Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphismsMITCHELL AOY TOMITA·Filed 2010·Granted Mar 4, 2014·7 cites·9 claims
- 0786US11773434B2Assessing transplant complication risk with total cell-free DNAMEDICAL COLLEGE WISCONSIN INC·Filed 2018·Granted Oct 3, 2023·2 cites·9 claims
- 0883US9181586B2Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphismsUNIV LOUISVILLE RES FOUND·Filed 2012·Granted Nov 10, 2015·2 cites·6 claims
- 0982US12290765B2Materials and methods for processing blood samplesNATERA INC·Filed 2024·Granted May 6, 2025·0 cites·14 claims
- 1077US2024401139A1Assessing graft suitability for transplantationNATERA INC·Filed 2024·Application pending·0 cites
- 1176US2024409989A1Methods for assessing risk using total and specific cell-free dnaMEDICAL COLLEGE WISCONSIN INC·Filed 2024·Application pending·0 cites
- 1275US2024229134A9Cell lysis assay for cell-free dna analysisNATERA INC·Filed 2023·Application pending·0 cites
- 1374US2020165678A1Highly sensitive transplant rejection surveillance using targeted detection of donor specific cell free dnaMEDICAL COLLEGE WISCONSIN INC·Filed 2019·Application pending·0 cites
- 1474US2024026437A1Assessing transplant complication risk with total cell-free dnaMEDICAL COLLEGE WISCONSIN INC·Filed 2023·Application pending·0 cites
- 1573US2020032340A1Highly sensitive surveillance using detection of cell free dnaMEDICAL COLLEGE WISCONSIN INC·Filed 2019·Application pending·0 cites
- 1669US2010184044A1Detecting Genetic AbnormalitiesUNIV LOUISVILLE RES FOUND·Filed 2009·Application pending·0 cites
- 1768US2024175071A1Methods for assessing cellular or tissue injury using mitochondrial and/or nuclear cell-free dnaMEDICAL COLLEGE WISCONSIN INC·Filed 2023·Application pending·0 cites
- 1864US12084720B2Assessing graft suitability for transplantationNATERA INC·Filed 2018·Granted Sep 10, 2024·0 cites·13 claims
- 1964US10081841B2Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphismsUNIV LOUISVILLE RES FOUND INC·Filed 2013·Granted Sep 25, 2018·0 cites·7 claims
- 2064US2023313303A1Compositions and methods for reducing cell-free dnaMEDICAL COLLEGE WISCONSIN INC·Filed 2022·Application pending·0 cites
- 2163US2023138927A1Methods for assessing the severity of, and for inhibiting, pro-inflammatory responses with total cell-free dnaMEDICAL COLLEGE WISCONSIN INC·Filed 2022·Application pending·0 cites
- 2263US2023399697A1Assessing risk with pre-operative total cell-free dnaMEDICAL COLLEGE WISCONSIN INC·Filed 2021·Application pending·0 cites
- 2361US2022145391A1Assessing risk with total cell-free dnaMEDICAL COLLEGE WISCONSIN INC·Filed 2021·Application pending·0 cites
- 2461US2010184043A1Detecting Genetic AbnormalitiesUNIV LOUISVILLE RES FOUND·Filed 2009·Application pending·0 cites
- 2559US2023167499A1Methods for assessing risk using total cell-free dnaMEDICAL COLLEGE WISCONSIN INC·Filed 2021·Application pending·0 cites
- 2659US2022356522A1Assessing conditions in transplant subjects using donor-specific cell-free dnaMEDICAL COLLEGE WISCONSIN INC·Filed 2021·Application pending·0 cites
- 2759US2022267849A1Transplant patient monitoring with cell-free dnaMEDICAL COLLEGE WISCONSIN INC·Filed 2021·Application pending·0 cites
- 2858US2019367972A1Methods for assessing risk using total and specific cell-free dnaMEDICAL COLLEGE WISCONSIN INC·Filed 2017·Application pending·0 cites
- 2957US2023257816A1Methods for making treatment management decisions in transplant subjects and assessing transplant risks with threshold valuesMITCHELL AOY TOMITA·Filed 2021·Application pending·0 cites
- 3054US2021301320A1Multiplexed optimized mismatch amplification (moma)-cancer risk assessment with non-cancer associated targetsMEDICAL COLLEGE WISCONSIN INC·Filed 2020·Application pending·0 cites
- 3153US2022340963A1Methods for assessing graft suitability for transplantationNORTH PAULA E·Filed 2020·Application pending·0 cites
- 3249US2021139988A1Assessing conditions in transplant subjects using donor-specific cell-free dnaMEDICAL COLLEGE WISCONSIN INC·Filed 2018·Application pending·0 cites
- 3349US2021139983A1Transplant patient monitoring with cell-free dnaMEDICAL COLLEGE WISCONSIN INC·Filed 2018·Application pending·0 cites
- 3447US2019360033A1Methods for assessing risk using mismatch amplification and statistical methodsMEDICAL COLLEGE WISCONSIN INC·Filed 2017·Application pending·0 cites
- 3546US2021032692A1Methods of determining donor cell-free dna without donor genotypeTAI DIAGNOSTICS INC·Filed 2018·Application pending·0 cites
- 3645US2020181681A1Multiplexed optimized mismatch amplification (moma)-real time pcr for assessing cancerMEDICAL COLLEGE WISCONSIN INC·Filed 2017·Application pending·0 cites
- 3745US2019153525A1Multiplexed optimized mismatch amplification (moma)-real time pcr for assessing fetal well beingMEDICAL COLLEGE WISCONSIN INC·Filed 2017·Application pending·0 cites
- 3845US2019153521A1Multiplexed optimized mismatch amplification (moma)-target numberMEDICAL COLLEGE WISCONSIN INC·Filed 2017·Application pending·0 cites
- 3943US2013143219A1Methods and compositions for high yield, specific amplificationMITCHELL AOY TOMITA·Filed 2011·Application pending·0 cites
- 4042US2018142296A1Multiplexed optimized mismatch amplification (moma)-real time pcr for assessing cell-free dnaMEDICAL COLLEGE OF WISCONSIN INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →